ARTV · Artiva Biotherapeutics Inc
United States · RS rating 26 · As of 2026-10-14
| Price | 5.91 USD |
|---|---|
| 1-day change | -6.0% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 5 / 9 / 96 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 36 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +33.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.9% |
| Market cap (USD) | $279.3M |